Current Management of CAD and the Role of Complement Activation

Shirley D'Sa

Diagnosis and Testing Considerations for Cold Agglutinin Disease

Julia Cunningham

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

CAD: The Basics and Development

Kelly Davidson

CAD: The Importance of Treatment Continuity

Sigbjørn Berentsen

Sutimlimab in Cold Agglutinin Disease

Kelly Davidson

2-Year Results From the CARDINAL Study: Sutimlimab for Complement C1…

Catherine Broome

Cold Agglutinin Disease: Pharmacologic Treatment and Clinical Monito…

Irina Murakhovskaya

CARDINAL Trial 2-Year Follow-Up: Long-Term Sutimlimab for Patients W…

Keck School of Medicine of USC

I. Weitz

Sutimlimab in Cold Agglutinin Disease: Safety From the Phase 3 Cardi…

Catherine Broome

Advances in Hemolytic Anemias: Enzymopathies, Membrane Defects, Auto…

Scripps Health

I. Weitz

Yale ASH Updates on Classical Hematology: PROs of Sutimlimab Use in …

Yale Cancer Center

G. Goshua